“Alert: Human Case of Crimean Congo Hemorrhagic Fever Confirmed at Dalal Jamm National Hospital Center in Guédiawaye, Senegal”

The Ministry of Health informed that the Dalal Jamm National Hospital Center in Guédiawaye confirmed a human case of Crimean Congo hemorrhagic fever on April 21, 2023. For this purpose, the Health Emergency Operations Center (COUS) was activated by Marie Khemess Ngom Ndiaye.

The document announces that the COUS has been activated following the confirmation of a case of Crimean Congo hemorrhagic fever at the Dalal Jamm National Hospital Center in Guédiawaye. Dr Mamadou Moustapha DIOP, Director of Disease Control, has been appointed Incident Manager.

→ READ ALSO: The State of Senegal takes an important decision for the family security grant

According to the WHO, Crimean-Congo hemorrhagic fever (CCHF) is caused by a virus (Nairovirus) of the Bunyaviridae family, transmitted by ticks. It causes outbreaks of severe viral haemorrhagic fever, with a case fatality rate of 10 to 40%. CCHF is endemic in Africa, the Balkans, the Middle East and Asia, in countries below 50 degrees north latitude, the geographical limit of the main vector species, a tick.

Although an inactivated vaccine has been developed against CCHF and used on a small scale in Eastern Europe, there is currently no safe, effective and widely available vaccine for humans. In the absence of a vaccine, raising public awareness of the risk factors and knowledge of the measures to be taken to reduce exposure to the virus remain the only means of reducing the risk of infection in humans.

→ READ ALSO: Incredible scene: His neighbors ask him to make less noise, he kills them!

→ READ ALSO: The strong testimony of Sadio Mané: “He asked me why I got angry and…”